Heart Failure and Incident Hematologic Malignancies: A Nationwide Population-Based Cohort Study

30 August 2026 (11:45 - 12:00)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor So-Young Lee

Seoul St. Marys Hospital, Seoul (Korea (Republic of))

3 More presentations in this session

Presentation thumbnail

A RAndomizeD Intervention for CArdiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

Doctor D. Leong (Hamilton, CA)

Presentation thumbnail

An open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2 targeted therapy related cardiac dysfunction.

Doctor B. Dowsing (London, GB)

Presentation thumbnail

Incidence and Predictors of Arterial Thrombosis in Cancer Patients: The Prospective COMPASS-Arterial Cancer Associated Thrombosis (COMPASS-ARTeCAT) Study

Doctor M. Drakopoulou (Athens, GR)

Access the full session

Session thumbnail

Late-Breaking Clinical Science: cardio-oncology

The Event

Event poster

ESC Congress 2026

30 August 2026 11:45 CET

You may be interested in

Congress Presentation

Cancer risks in heart failure patients: Insights from ischemic and non-ischemic cardiomyopathy

21 June 2025

Congress Session

From genetic signatures to clinical implications

18 May 2025

Webinar

How to manage cancer therapy-related cardiovascular toxicity. ESC 2022 Clinical Practice Guidelines - Webinar Series

19 September 2022

Congress Presentation

Characterizing patients with heart failure with reduced ejection fraction and history of malignancy: data from the Swedish heart failure registry.

11 May 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources